Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01XTN
|
|||
| Former ID |
DIB014651
|
|||
| Drug Name |
Epaxal
|
|||
| Synonyms |
HAVpur; Epaxal Berna; Epaxal Junior; HAVpur Junior; VIROHEP-A; Virosome-formulated Hepatitis A vaccine, Berna/Crucell; Low-dose Epaxal (pediatric), Berna/Crucell
Click to Show/Hide
|
|||
| Indication | Hepatitis A virus infection [ICD-11: 1E50.0] | Approved | [1], [2] | |
| Company |
Berna Biotech AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT01349829) A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.